It is estimated that there are as many as 1400 plant species currently used in traditional Peruvian medicine; however, only a few have undergone scientific investigation. In this paper, we make a review of the botanical, chemical, pharmacological and clinical propierties of the most investigated Peruvian medicinal plants. The plant species selected for this review are: Smallanthus sonchifolius (yacon), Croton lechleri (sangre de grado), Uncaria tomentosa/U. guianensis (uña de gato), Lepidium meyenii (maca), Physalis peruviana (aguaymanto), Minthostachys mollis (muña), Notholaena nívea (cuti-cuti), Maytenus macrocarpa (chuchuhuasi), Dracontium loretense (jergon sacha), Gentianella nitida (hercampuri), Plukenetia volubilis (sacha inchi) and Zea mays (maiz morado). For each of these plants, information about their traditional uses and current commercialization is also included.
World Health Organization (2002) WHO Traditional Medicine Strategy 2002–2005. Geneva. WHO, p 1.
2.
CabiesesF. (1993) Apuntes sobre Medicina Tradicional, la racionalización de lo irracional. Tomo II., Talleres de A& B, S.A.Lima.
3.
MejíaK, RengifoE. (2000) Plantas Medicinales de Uso Popular en la Amazonía Peruana. (2da. ed.). Agencia Española de Cooperación Internacional, Lima, 284 pp.
4.
VillarM, VillavicencioO. (2000) Manual de fitoterapia. EsSalud/OPS. Lima, 405 pp.
5.
BusssmanRW, SharonD. (2014) Two decades of ethnobotanical research in Southern Ecuador and Northern Peru. Ethnobiology and Conservation, 3, 1–50.
6.
SoukupJ. (1970) Vocabulario de los nombres vulgares de la flora peruana y catálogo de los géneros. Ed. Salesiana, Lima, 436 pp.
7.
MostaceroJ, CastilloF, MejíaF, GamarraO, CharcapeJ, RamirezR. (2011) Plantas medicinales del Perú: Taxonomía, Ecografía, Fenología y Etnobotánica. Asamblea Nacional de Rectores. 909 pp.
8.
DostertN, RoqueJ, CanoA, La TorreM, WeigendM. (2009) Hojas botánicas: Yacón- Smallanthus sonchifolius (Poepp.) H. Rob. Proyecto Perúbiodiverso – PBD: Deutsche Gesellschaft für Technische Zusammenarbeit (GTZ) GmbH: Programa Desarrollo Rural Sostenible – PDRS.
9.
CárdenasU. (1969) Manual de plantas económicas de Bolivia. Imprenta Icthus, Cochabamba. 333 pp.
10.
SeminarioJ, ValderramaM, ManriqueI. (2003) El Yacón: fundamentos para el aprovechamiento de un recurso promisorio. Centro Internacional de la Papa (CIP), Universidad Nacional de Cajamarca, Agencia Suiza para el Desarrollo y la Cooperación (COSUDEL), Lima, pp. 25–33.
11.
SánchezS, GentaS. (2007) Yacón: un potencial producto natural para el tratamiento de la diabetes. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, 6, 162–164.
12.
HurrelJA, PochettinoML, PuentesJP, ArenasPM. (2013) Del marco tradicional al escenario urbano: plantas ancestrales devenidas suplementos dietéticos en la urbanización de Buenos Aires, La Plata, Argentina. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas, 12, 499–515.
13.
GotoK, FukaiK., HikidaJ, NanjoF, HaraY. (1995) Isolation and structural analysis of oligosaccharides from yacon (Polymnia sonchifolia). Bioscience, Biotechnology and Biochemistry, 59, 2246–2347;
14.
PedreschiR, CamposD, NorattoC, ChirinosR, Cisneros-ZevallosL. (2003) Andean yacon root (Smallanthus sonchifolius Poepp. Endl). fructooligosaccharides as a potential novel source of prebiotics. Journal of Agricultural and Food Chemistry, 51, 5278–5284.
15.
YanX, SuzukiM, Ahnishi-KameyamaM, SadaY, NakanishiT, NagataT. (1999) Extraction and identification of antioxidants in the roots of yacon. Journal of Agricultural and Food Chemistry, 47, 4711–4713;
16.
TakenakaM, VanX, OnoH, YoshidaM, NagataT, NakanishiT. (2003) Caffeic acid derivatives in the roots of yacon. Journal of Agricultural and Food Chemistry, 51, 793–796;
17.
TakenakaM, OnoH. (2003) Novel octulosonic acid and derivatives in the composite Smallanthus sonchifolius. Tetrahedron Letters, 44, 999–1002;
18.
SimonovskaB, VovkI, AndrensekS, ValentováK, UlrichováJ. (2003) Investigation on phenolic acids in yacon. Journal of Chromatography A, 1016, 89–98.
19.
LizárragaL, OrtegaR, VargasM, VidalA. (1997) Cultivo del yacón (Polymnia sonchifolia). En Andean Roots and Tubers: ahipa, arracacha, maca, yacon. HermannM. and HellerJ. Eds. Institute of Plant Genetic and Crop Plant Research, p. 222.
20.
InoueA, TamogamiS, KatoH, NakazatoY, AkiyamaM, KodamaO, AkatsukaT, HashidokoY. (1995) Antifungal melampolides from leaf extracts of Smallanthus sonchifolius. Phytochemistry, 39, 845–848;
21.
LinF, HasegawaM, KodamaO. (2003) Purification and identification of antimicrobial sesquiterpene lactones from yacon (Smallanthus sonchifolius) leaves. Bioscience, Biotechnology and Biochemistry, 67, 2154–2159;
22.
KakutaH, SekiT, HashidokoY, MizutaniJ. (1992) Ent-kaurenoic acid and its related compounds from glandular trichome exudate and leaf extract of Polymnia sonchifolia.Bioscience, Biotechnology and Biochemistry, 56, 1562–1564;
23.
DouDQ, TianF, QiuYK, XiangZ, XuBX, KangTG, DongF. (2010) Studies on chemical constituents of the leaves of Smallanthus sonchifolius (yacon): Structures of two new diterpenes. Natural Products Research, 24, 40–47;
24.
DouDQ, TianF, QiuYK, KangTG, DongF. (2008) Structure elucidation and complete NMR spectral assignments of four new diterpenoids from Smallanthus sonchifolius. Magnetic Resonance in Chemistry, 46, 775–779;
25.
MercadoMI, Coll AráozMV, GrauA, CatalánC. (2010) New acyclic diterpenic acids from yacon (Smallanthus sonchifolius) leaves. Natural Product Communications, 5, 1721–1726.
26.
De AndradeEF, de SozaR, EllendersenLN, MassonML. (2014) Phenolic profile and antioxidant activity of extracts of leaves and flowers of yacon (Smallanthus sonchifolius). Industrial Crops and Products, 62, 499–506.
27.
ValentováK, CvakL, MuckA, UlrichováJ, SimanekV. (2003) Antioxidant activity of extracts from the leaves of Smallanthus sonchifolius. European Journal of Nutrition, 42, 61–66.
28.
PadlaEP, SolisLT, RagasaCY. (2012) Antibacterial and antifungal properties of ent-kaurenoic acid from Smallanthus sonchifolius.Chinese Journal of Natural Medicines, 10, 408–414;
29.
ChoiJG, KangOH, LeeYS, OhYC, ChaeHS, Obiang-ObounouB, ParkSC, ShinDW, HwangBY, KwonDY. (2010) Antimicrobial activity of the constituents of Smallanthus sonchifolius leaves against methicillin-resistant Staphylococcus aureus.European Review for Medical and Pharmacological Sciences, 14, 1005–1009;
30.
FrankFM, UlloaJ, CazorlaSI, MaravillaG, MalchiodiEL, GrauA, MartinoV, CatalánC, MuschiettiLV. (2013) Trypanocidal activity of Smallanthus sonchifolius: Identification of active sesquiterpene lactones by bioassay-guided fractionation. Evidence-based Complementary and Alternative Medicine, 62789.
31.
OliveiraRB, Chagas-PaulaDA, SecattoA, GasparotoTH, FaccioliLH, CampanelliAP, da CostaFB. (2013) Topical anti-inflammatory activity of yacon leaf extracts. Brazilian Journal of Pharmacognosy, 23, 497–505.
32.
AybarM., SánchezA, GrauA, SánchezS. (2001) Hypoglycemic effect of the water extract of Smallantus sonchifolius (yacon) leaves in normal and diabetic rats. Journal of Ethnopharmacology, 74, 125–132;
33.
ValentováK, MoncionA, de WaziersI, UlrichováJ. (2004) The effect of Smallantus sonchifolius leaf extracts on rat hepatic metabolism. Cell Biology and Toxicology, 20, 109–120;
34.
ValentováK, UlrichováJ. (2003) Smallanthus sonchifolius and Lepidium meyenii – Prospective andean crops for the prevention of chronic diseases. Biomedical Papers, 147, 119–130;
35.
GentaSB, CabreraWM, MercadoMI, GrauA, CatalánCA, SánchezSS. (2010) Hypoglycemic activity of leaf organic extracts from Smallanthus sonchifolius: Constituents of the most active fractions. Chemico-Biological Interactions, 185, 143–152;
36.
RagaDD, AlimboyoguenAB, Del FierroRS, RagasaCY. (2010) Hypoglycaemic effects of tea extracts and ent-kaurenoic acid from Smallanthus sonchifolius. Natural Product Research, 24, 1771–1782;
Ornelas OliveiraG, Pereira BragaC, Henrique FernandesAA. (2013) Improvement of biochemical parameters in type 1 diabetic rats after the roots aqueous extract of yacon [Smallanthus sonchifolius (Poepp. & Endl.)] treatment. Food and Chemical Toxicology, 59, 256–260;
39.
ParkJS, YangJS, HwangBY, YooBK, HanK. (2009) Hypoglycemic effect of yacon tuber extract and its constituent, chlorogenic acid, in streptozotocin-induced diabetic rats. Biomolecules and Therapeutics, 17, 256–262.
40.
CamposD, Betalleluz-PallardelI, ChirinosR, Aguilar-GálvezA, NorattoG, PedreschiR. (2012) Prebiotic effects of yacon (Smallanthus sonchi-folius Poepp. & Endl), a source of fructooligosaccharides and phenolic compounds with antioxidant activity. Food Chemistry, 135, 1592–1599
41.
GordilloG, NegrónLP, ZúñigaTH, FloresE, MoreyraR, FuertesC, GuerraGA, ApesteguíaA, QuintanaAM. (2012) Efecto hipoglicemiante del extracto acuoso de las hojas de Smallanthus sonchifolius (Yacón) en pacientes con diabetes mellitus tipo II. Ciencia e Investigación, 15, 42–47;
42.
MaytaP, PayanoJ, PeláezJ, PérezM, PichardoL, PuycánL. (2004) Reducción de la respuesta glicémica posprandial post-ingesta de raíz fresca de yacón en sujetos sanos. Ciencia e Investigación Médica Estudiantil Latinoamericana, 8, 7–11;
43.
LudeñaA, UgarteK, BelsuzarriI. (2004) Efecto normoglicemiante del tubérculo y la hoja del yacón (Smallantus sonchifolius) en pacientes diabéticos tipo II. Revista Horizonte Médico, Jun, 64–65.
44.
GeyerM, ManriqueI, DegenL, BeglingerC. (2008) Effect of yacon (Smallanthus sonchifolius) on colonic transit time in healthy volunteers. Digestion, 78, 30–33.
45.
CalvinoM. (1940): Una nuova pianta da foraggio e da alcole: La Polymnia edulis. Industria Saccarifera Italiana, 33, 95–98.
DouglasJA, DouglasMH; DeoB; FollettJM; SchefferJJC; SimsIM, WelchRAS. (2005) Research and development of Yacón (Smallanthus sonchifolius) production in New Zealand. Acta Horticulturae, 670, 79–85.
World Intellectual Property Organization. (2005) Intergovernmental Committee on Intellectual Property and Genetic Resources Traditional Knowledge and Folklore. Patent System and the Fight against Biopiracy - The Peruvian Experience. WIPO/GRTKF/IC/8/12.
Mac BrideJ.Francis (1936) Flora of Peru. Field Museum of Natural History Botany. Vol. XIII
54.
BrackA. (1999) Diccionario Enciclopédico de Plantas útiles del Perú. CERA Bartolomé de las Casas-PNUD. Cusco, 556pp.
55.
MarceloAJ, CalderónC, MedinaD, ValenciaM, ParionaM & MezaEN (1999) Desarrollando nuestra diversidad biocultural: “Sangre de Grado” y el reto de su producción sustentable en el Perú. Universidad Nacional Mayor de San Marcos Lima. 259pp.
56.
RiscoE, IglesiasT. (2001) Sangre de drago; interés terapéutico del látex de Croton lechleri.12me. Forum De Natura Rerum, París, 20–21 octubre.
57.
Instituto Peruano de Seguridad Social (2005) Plantas medicinales de la Amazonía Peruana. IPSS, Lima, p. 36–37.
UbillasR, JoladSD, BrueningRC, KemanMR, KingSR, SesinDF, BarretM, StoddartCA, FlasterT, KuoJ, AyalaF, MezaE, CastañelM, Mc MeekinD, RozhonE, TempestaMS, BarnardD, HuffmanJ, SmeeD, SidwellR, SoikeK, BrazierA, SafrinS, OrlandoR, KennyPT, BerovaN, NakanishiK. (1994) SP–303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Grado). Phytomedicine, 1, 77–106.
60.
PerdueGP, BlomsterRN, BlakeDA, FarnsworthNR. (1979) South American plants II: taspine isolation and anti-inflammatory activity. Journal of Pharmaceutical Sciences, 68, 124–126.
61.
PietersL, de BruyneT, ClaeysM, VlietinckA, CalommeM, vanden BergheD. (1993) Isolation of a dihydrobenzofuran lignan from South American dragon's blood (Croton spp.) as an inhibitor of cell proliferation. Journal of Natural Products, 56, 899–906.
De MarinoS, GalaF, ZolloF, VitalinoS, FicoG, VisioliF, IorizziM. (2008) Identification of minor secondary metabolites from the latex of Croton lechleri (Muell-Arg) and evaluation of their antioxidant activity. Molecules, 13, 1219–1229.
65.
BellesiaF, PinettiA, TirilliniB. (1996) Headspace analysis of Croton lechleri L. sap. Journal of Essential Oil Research, 8, 435–437;
66.
RossiD, GuerriniA, MaiettiS, BruniR, PaganettoG, PoliF, ScalvenziL, RadiceM, SaroK, SacchettiG. (2011) Chemical fingerprint and bioactivity of Amazonian Ecuador Croton lechleri Muell. Arg. (Euphorbiaceae) stem bark essential oil: A new functional food ingredient?Food Chemistry, 126, 837–848.
67.
CarlinL, VaisbergA, HammondG. (1996) Isolation of sinoacutine from the leaves of Croton lechleri. Planta Medica, 62, 90–91;
68.
MilanowskiDJ, WinterRE, Elvin-LewisMP, LewisWH. (2002) Geographic distribution of three alkaloid chemotypes of Croton lechleri. Journal of Natural Products, 65, 814–819.
DesmarchelierC, Witting SchausF, CoussioJ, CiccaG. (1997) Effects of sangre de drago from Croton lechleri Muell.-Arg. on the production of active oxygen radicals. Journal of Ethnopharmacology, 58, 103–108;
71.
DesmarchelierCJ, de Moraes BarrosSB. (2003) Pharmacological activity of South American plants: effects on spontaneous in vivo lipid peroxidation. Phytotherapy Research, 17, 80–82;
72.
RiscoE, GhiaF, VilaR, IglesiasJ, AlvarezE, CañigueralS. (2003) Immunomodulatory activity and chemical characterisation of Sangre de Drago (Dragon's Blood) from Croton lechleri. Planta Medica, 69, 785–794.
73.
ChenZP, CaiY, PhillipsonJ. (1994) Studies on the anti-tumour, anti-bacterial, and wound-healing properties of dragon's blood. Planta Medica, 60, 541–545.
74.
ItokawaH, IchiharaY, MochizukiM, EnomoriT, MoritaH, ShirotaO, InamatsuM, TakeyaK. (1991) A cytotoxic substance from Sangre de Grado. Chemical and Pharmaceutical Bulletin, 39, 1041–1042;
75.
MontopoliM, BertinR, ChenZ, BolcatoJ, CaparrottaL, FroldiG. (2012) Croton lechleri sap and isolated alkaloid taspine exhibit inhibition against human melanoma SK23 and colon cancer HT29 cell lines. Journal of Ethnopharmacology, 144, 747–753;
76.
FayadW, FryknäsM, BrnjicS, OlofssonMH, LarssonR, LinderS. (2009) Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters. PLoS ONE, 4, e7238.
77.
RossiD, BruniR, BianchiN, ChiarabelliC, GambariR, MediciA, ListaA, PaganettoG. (2003) Evaluation of the mutagenic, antimutagenic and antiproliferative potential of Croton lechleri (Muell. Arg.) latex. Phytomedicine, 10, 139–144;
78.
LopesMI, SaffiJ, EcheverrigarayS, HenriquesJA, SalvadorM. (2004) Mutagenic and antioxidant activities of Croton lechleri sap in biological systems. Journal of Ethnopharmacology, 95, 437–445.
79.
PereiraU, Garcia-LeGal C, LeGal G, BoulaisN, LebonvalletN, DorangeG, LefeuvreL, GougerotA, MiseryL. (2010) Effects of sangre de drago in an in vitro model of cutaneous neurogenic inflammation. Experimental Dermatology, 19, 796–799;
80.
MillerMJS, VergnolleN, McKnightW, MusahRA, DavisonCA, TrentacostiAMThompsonJH, SandovalM, WallaceJL. (2001) Inhibition of neurogenic inflammation by the Amazonian herbal medicine sangre de grado. Journal of Investigative Dermatology, 117, 725–730.
81.
RiscoE, GhiaF, VilaR, IglesiasJ, AlvarezE, CañigueralS. (2003) Immunomodulatory activity and chemical characterisation of Sangre de Drago (Dragon's Blood) from Croton lechleri. Planta Medica, 69, 785–794;
82.
PersinosP, BlomsterRN, BlakeDA, FarnsworthNR. (1979) South American plants II: Taspine isolation and anti-inflammatory activity. Journal of Pharmaceutical Sciences, 68, 124–126.
83.
VaisbergAJ, MillaM, PlanasMC, CórdovaJL, Rosas de AgustiE, FerreyraR, MústigaMC, CarlínL, HammondGB. (1989) Taspine is the cicatrizant principle in sangre de grado extracted from Croton lechleri. Planta Medica, 55, 140–143;
84.
Porras-ReyesBH, LewisWH, RomanJ, SimchowitzL, MustoeTA. (1993) Enhancement of wound healing by the alkaloid taspine defining mechanism of action. Proceedings of the Society for Experimental Biology and Medicine, 203, 18–25.
85.
PietersL, De BruyneT, MeiG, LemièreG, Vanden BergheD, VlietinckAJ. (1992) In vitro and in vivo biological activity of South American Dragon's Blood and its constituents. Planta Medica, 58, Suppl. 1, A582–A583;
86.
PietersL, De BruyneT, Van PoelR. VingerhoetsR, TottéJ, Vanden BergheD, VlietinckA. (1995) In vivo wound healing activity of Dragon's Blood (Croton spp.), a traditional South American drug, and its constituents. Phytomedicine, 2, 17–22.
87.
MillerMJS, MacNaughtonWK, ZhangX-J, ThompsonJH, CharbonnetRM, BobrowskiP, LaoJ, TrentacostiAM, SandovalM. (2000) Treatment of gastric ulcers and diarrhea with the Amazonian herbal medicine sangre de grado. American Journal of Physiology Gastrointestinal. Liver Physiology, 279, G192-G200.
88.
GabrielSE, DavenportSE, SteagallRJ, VimalV, CarlsonT, RozhonEJ. (1999) A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion. American Journal of Physiology, 276, G58–G63;
89.
FischerH, MachenTE, WiddicombeJH, CarlsonTJS, KingSR, ChowJWS, IllekB. (2004) A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells. Journal of Ethnopharmacology, 93, 351–357.
90.
DiCesareD, DuPontHL, MathewsonJJ, AshleyD, Martínez-SandovalF, PenningtonJE, PorterSB. (2002) A double blind, randomized, placebo-controlled study of SP–303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and MexicoStudy of SP 303 (Provir) for travelers’ diarrhea. American Journal of Gastroenterology, 97, 2585–2588;
91.
TradtrantipL, NamkungW, VerkmanAS. (2010) Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels. Molecular Pharmacology, 77, 69–78;
92.
FramptonJE. (2013) Crofelemer: A review of its use in the management of non-infectious diarrhoea in adult patients with HIV/AIDS on antiretroviral therapy. Drugs, 73, 1121–1129.
93.
ChordiaP, MacArthurRD. (2013) Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons. Expert Review of Gastroenterology & Hepatology, 7, 591–600;
94.
HolodniyM, KochJ, MistaM, SchmidtM, KhandwalaA, PenningtonE, PorterB. (1999) A double blind, randomized, placebo controlled phase II study to assess the safety and efficacy of orally administered SP-303 for symptomatic treatment of diarrhoea in patients with AIDS. American Journal of Gastroenterology, 94, 3267–3273;
95.
Orozco-TopeteR, Sierra-MaderoJ, Cano-DomínguezC, KershenovichJ, Ortiz-PedrozaG, Vázquez-VallsE, RozhonJ. (1997) Safety and efficacy of Virend® for topical treatment of genital and anal herpes simplex lesions in patients with AIDS. Antiviral research, 35, 91–103.
International Trade Centre (ITC). (2012) The North American Market for Natural Products Prospects for Andean and African Products. Retrieved from: www.intracen.org/WorkArea/DownloadAsset.aspx?id=58174. [Accessed Nov 11, 2014].
98.
US Food and Drug Administration (FDA). (February 1, 2005) Comments of the Utah Natural Products Alliance on the Food and Drug Administration's Request for Comment on FDA's Premarket Notification Program for New Dietary Ingredients. US website. Retrieved from: www.fda.gov/ohrms/dockets/dockets/04n0454/04n-0454-c000014-01-vol5.pdf. [Accessed Sep 8, 2014].
RutterAR (1990) Catálogo de las Plantas Útiles de la Amazonía Peruana. Ministerio de Educación – Instituto Lingüístico de Verano, Yanacocha, Pucallpa, Perú.
101.
SoukupJ. (1973) Las Rubiáceas del Perú, sus géneros y lista de especies. Biota IX, 74, 315–399.
102.
UrrunagaSR. (1993) Investigación etnobotánica de las especies del género Uncaria, Rubiaceae. Centro de Plantas Medicinales. Universidad Nacional San Antonio Abad del Cuzco. CEPLAM – UNSAAC. VI Congreso Peruano de Farmacia y Bioquímica and II Congreso Italoandino de Etnomedicina. Lima, Perú.
103.
SilvaDH, AlvaradoDR, HidalgoHJ, CerruttiST, GarciaRJ, DávilaMW, MestanzaDM, RiosIF, NinaCE, NonatoLR. (1998) Monografia de Uncaria tomentosa (Willd.) DC. Instituto Peruano de Seguridad Social-Instituto de Medicina Tradicional. Iquitos, Perú. 103pp;
104.
RengifoE.Contribución de la etnomedicina de las plantas medicinales en la salud de la población en la Amazonía.Instituto de Investigación de la Amazonía Peruana, Iquitos, p.204.
105.
WilliamsJE. (2001) Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on uña de gato and sangre de grado. Alternative Medicine Reviews, 6, 567–579;
106.
AlonsoJ. (2004) Tratado de fitofármacos y nutracéuticos. Corpus, Rosario, Argentina1056–1057.
107.
PhillipsonJD, HemingwaySR. (1978) Alkaloids of Uncaria. Journal of Natural Products, 41, 503–571;
108.
HemingwaySR, PhillipsonJD. (1974) Alkaloids from S. American species of Uncaria (Rubiaceae). Journal of Pharmacy and Pharmacology, 26, 113P, doi:10.1111/j.2042-7158.1974.tb10144.x.;
109.
Montenegro deMatta S, Delle MonacheF, FerrariF, Marini BettoloGB. (1976) Alkaloids and procyanidins of an Uncaria sp. from Peru. Il Farmaco, 7, 527–535;
110.
WagnerH, KreutzkampB, JurcicK, (1985) Die alkaloide von Uncaria tomentosa und ihre phagozytose stegernde Wirkung. Planta Medica, 51, 419–422.
111.
AlvarezC, SánchezO, StilkeR, Lock de UgazO. (1988) Algunos constituyentes de Uncaria guianensis. Revista de Química PUCP, 2, 99–104;
112.
KitajimaM, HashimotoKI, YokoyaM, TakayamaH, AimiN, SakaiST. (2000) A new glicoindole alkaloid, 3,4-dihydro-5-carboxistrictosidina, from the Peruvian uña de gato. Chemical & Pharmaceutical Bulletin, 48, 1410–1412.
CerriR, AquinoR, de SimoneF, PizzaC. (1988) New quinovic and glycosides from Uncaria tomentosa. Journal of Natural Products, 51, 257–261;
115.
AquinoR, de SimoneF, PizzaC, SteinML. (1989) Structure and in vitro antiviral activity of quinovic acid glycosides from Uncaria tomentosa and Guettarda platypoda.Journal of Natural Products, 52, 679–685;
116.
AquinoR, de FeoB, de SimoneF, PizzaC, CirinoG. (1991) Plant metabolites. New compounds and anti-inflammatory activity of Uncaria tomentosa. Journal of Natural Products, 54, 453–459;
117.
YépezAM, LockO, AlvarezC, de FeoV, AquinoR, de SimoneF, PizzaC. (1991) Quinovic acid glycosides from Uncaria guianensis. Phytochemistry, 30, 1635–1637;
118.
AquinoR, De TommasiN, PizzaC. (1997) Triterpenes and quinovic acid glycosides from Uncaria tomentosa. Phytochemistry, 45, 1035–1040;
119.
CalloN, HenostrozaR, LockO. (1997) Constituents of Uncaria guianensis. Boletín de la Sociedad Química del Perú, 63, 124.
120.
QuintelaJC, LockO. (2003) Uña de gato. Uncaria tomentosa (Willd.) DC. Revista de Fitoterapia, 3, 5–18.
121.
AquinoR, de SimoneF, PizzaC. (1990) New polyhidroxylated triterpenes from Uncaria tomentosa. Journal of Natural Products, 53, 559–564;
122.
SenatoreA, CataldoA, IacarinoFF, ElbertiMG. (1989) Richerchi fitochimiche e biologiche sull Uncaria tomentosa. Bollettino- Societa Italiana Biologia Sperimentale, LXV, 575–580;
123.
KitajimaM, HashimotoK, YokoyaM, TakayamaH, AimiN. (2000) Two new 19-hydroxyursolic acid-type triterpenes from Peruvian “uña de gato” (Uncaria tomentosa).Tetrahedron, 56, 547–552;
124.
KitajimaM, HashimotoKI, YokoyaM, TakayamaH, SandovalM, AimiN. (2003) Two new nor-triterpene glycosides from Peruvian “Uña de Gato” (Uncaria tomentosa).Journal of Natural Products, 66, 320–330;
125.
MuhammadI, DunbarDC, KhanRA, GanzeraM, KhanIA. (2001) Investigation of Uña de Gato. 7-deoxyloganic acid and 15N NMR spectroscopic studies on pentacyclic oxindole alkaloids from Uncaria tomentosa. Phytochemistry, 57, 781–785.
126.
WirthC, WagnerH. (1997) Pharmacologically active procyanidines from the bark of Uncaria tomentosa. Phytomedicine, 4, 265–266;
127.
ShengY, AkessonC, HolmgrenK, BryngelssonC, GiamapaV, PeroRW. (2005) An active ingredient of cat's claw extracts. Identification and efficacy of quinic acid. Journal of Ethnopharmacology, 96, 577–584.
128.
PilarskiR, Zieli'nskiH, CiesiołkaD, GulewiczK. (2006) Antioxidant activity of ethanolic and aqueous extracts of Uncaria tomentosa (Willd.) DC. Journal of Ethnopharmacology, 104, 18–23;
129.
GonçalvesC, DinisT, BatistaMT. (2005) Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: A mechanism for anti-inflammatory activity. Phytochemistry, 66, 89–98;
130.
DesmarchelierC, MongelliE, CoussioJ, CicciaG. (1996) Investigations into the antioxidant activity of two medicinal plants used as anti-inflammatory in South America. Anales de la Real Academia de Farmacia, 62, 357–373;
131.
DesmarchelierC, MongelliE, CoussioJ, CicciaG. (1997) Evaluation of the in vitro antioxidant activity in extracts of Uncaria tomentosa (Willd.) DC. Phytotherapy Research, 11, 254–256.
132.
CorreiaAF, SegoviaJFO, GonçalvesMCA, De OliveiraVL, SilveiraD, CarvalhoJCT, KanzakiLIB. (2008) Amazonian plant crude extracts screening for activity against multidrug-resistant bacteria. European Review for Medical and Pharmacological Sciences, 12, 369–380;
133.
Ccahuana-VasquezRA, Ferreira dos SantosSS, Koga-ItoCY, Cardoso JorgeAO. (2007) Antimicrobial activity of Uncaria tomentosa against oral human pathogens. Brazilian Oral Research, 21, 46–50;
134.
GarcíaR, CayunaoC, BocicR, BackhouseN, DelporteC, ZaldivarM, ErazoS. (2005) Antimicrobial activity of isopteropodine, Zeitschrift fur Naturforschung - Section C Journal of Biosciences, 60, 385–388;
135.
Prieto RodríguezJA, Patiño LadinoOJ, LesmesL, LozanoJM, Cuca SuárezLE. (2011) Phytochemical study of Uncaria guianensis leaves and antibacterial activity evaluation. Acta Amazonica, 41, 303–310;
136.
CaonT, KaiserS, FeltrinC, de CarvalhoA, SinceroTCM, OrtegaGG, SimõesCMO. (2014) Antimutagenic and antiherpetic activities of different preparations from Uncaria tomentosa (cat's claw). Food and Chemical Toxicology, 66, 30–35;
137.
ReisSRIN, ValenteLMM, SampaioAL, SianiAC, GandiniM, AzeredoEL, D'AvilaLA, MazzeiJL, HenriquesMdGM, KubelkaCF. (2008) Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with dengue virus-2. International Immunopharmacology, 8, 468–476;
138.
Lima-JuniorRS, Mello CdaS, SianiAC, ValenteLMM, KubelkaCF. (2013) Uncaria tomentosa alkaloidal fraction reduces paracellular permeability, IL-8 and NS1 production on human microvascular endothelial cells infected with dengue virus. Natural Product Communications, 8, 1547–1550.
139.
RivaL, CoradiniD, Di FronzoG, De FeoV, De TommasiN, De SimoneF, PizzaC. (2001) The antiproliferative effects of Uncaria tomentosa extracts and fractions on the growth of breast cancer cell line. Anticancer Research, 21, 2457–2461;
140.
PilarskiR, Poczekaj-KostrzewskaM, CiesiołkaD, SzyfterK, GulewiczK. (2007) Antiproliferative activity of various Uncaria tomentosa preparations on HL-60 promyelocytic leukemia cells. Pharmacological Reports, 59, 565–572;
141.
García GiménezD, García PradoE, Sáenz RodríguezT, Fernández ArcheA, De La PuertaR. (2010) Cytotoxic effect of the pentacyclic oxindole alkaloid mitraphylline isolated from Uncaria tomentosa bark on human Ewing's sarcoma and breast cancer cell lines. Planta Medica, 76, 133–136;
142.
García PradoE, García GimenezMD, De la Puerta VázquezR, Espartero SánchezJL, Sáenz RodríguezMT. (2007) Antiproliferative effects of mitraphylline, a pentacyclic oxindole alkaloid of Uncaria tomentosa on human glioma and neuroblastoma cell lines. Phytomedicine, 14, 280–284;
143.
Paniagua-PérezR, Madrigal-BujaidarE, Molina-JassoD, Reyes-CadenaS, Álvarez-GonzálezI, Sánchez-ChapulL, Pérez-GallagaJ. (2009) Antigenotoxic, antioxidant and lymphocyte induction effects produced by pteropodine. Basic and Clinical Pharmacology and Toxicology, 104, 222–227;
144.
BacherN, TiefenthalerM, SturmS, StuppnerH, AusserlechnerMJ, KoflerR, KonwalinkaG. (2006) Oxindole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2-expressing acute lymphoblastic leukaemia cells. British Journal of Haematology, 132, 615–622.
145.
FazioAL, BallénD, CesariIM, AbadMJ, ArsenakM, TaylorP. (2008) An ethanolic extract of Uncaria tomentosa reduces inflammation and B16-BL6 melanoma growth in C57BL/6 mice. Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, 7, 217–224;
146.
DreifussAA, Bastos-PereiraAL, FabossiIA, LıveroFAdR, StolfAM, Alves de SouzaCA, de Oliveira GomesL, ConstantinRP, FurmanAEF, LaurianoR, StrapassonB, TeixeiraS, ZampronioAR, MuscaraMN, StefanelloMEA, AccoA. (2013) Uncaria tomentosa exerts extensive antineoplastic effects against the Walker-256 tumour by modulating oxidative stress and not by alkaloid Activity. PLoS ONE, 8, e54618.
147.
ShengY, PeroRW, AmiriA, BryngelssonC. (1998) Induction of apoptosis and inhibition of proliferation in human tumor cells treated with extracts of Uncaria tomentosa. Anticancer Research, 18, 3363–3368;
148.
ÅkessonC, LindgrenH, PeroRW, LeandersonT, IvarsF. (2003) An extract of Uncaria tomentosa inhibiting cell division and NF-κB activity without inducing cell death. International Immunopharmacology, 3, 1889–1900;
149.
ÅkessonC, LindgrenH, PeroRW, LeandersonT, IvarsF. (2005) Quinic acid is a biologically active component of the Uncaria tomentosa extract C-Med 100®. International Immunopharmacology, 5, 219–229;
150.
MammoneT, ÅkessonC, GanD, GiampapaV, PeroRW. (2006) A water soluble extract from Uncaria tomentosa (Cat's claw) is a potent enhancer of DNA repair in primary organ cultures of human skin. Phytotherapy Research, 20, 178–183.
151.
AguilarJL, RojasP, MarceloA, PlazaA, BauerR, ReiningerE, KlaasCA, MerfortI. (2002) Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae). Journal of Ethnopharmacology, 81, 271–276;
152.
CarvalhoMV, PenidoC, SianiAC, ValenteLMM, HenriquesMGMO. (2006) Investigations on the anti-inflammatory and anti-allergic activities of the leaves of Uncaria guianensis (Aublet) J. F. Gmelin. Inflammopharmacology, 14, 48–56.
153.
UrdanibiaI, MichelangeliF, RuizM-C, MilanoB, TaylorP. (2013) Anti-inflammatory and antitumoural effects of Uncaria guianensis bark. Journal of Ethnopharmacology, 150, 1154–1162.
154.
SandovalM, CharbonnetRM, OkuhamaNN, RobertsJ, KrenovaZ, TrentacostiAM, MillerMJS. (2000) Cat's claw inhibits TNF-α production and scavenges free radicals: Role in cytoprotection. Free Radical Biology and Medicine, 29, 71–78;
155.
PiscoyaJ, RodriguezZ, BustamanteSA, OkuhamaNN, MillerMJS, SandovalM. (2001) Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: Mechanisms of action of the species Uncaria guianensis. Inflammation Research, 50, 442–448;
156.
LemaireI, AssineweV, CanoP, AwangDVC, ArnasonJT. (1999) Stimulation of interleukin-1 and -6 production in alveolar macrophages by the neotropical liana, Uncaria tomentosa (Una de Gato). Journal of Ethnopharmacology, 64, 109–115;
157.
Allen-HallL, CanoP, ArnasonJT, RojasR, LockO, LafrenieRM. (2007) Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression if IL-1β and TNF-α. Journal of Ethnopharmacology, 109, 312–317;
158.
SandovalM, OkuhamaNN, ZhangX-J, CondezoLA, LaoJ, AngelesFM, MusahRA, BobrowskiP, MillerMJS. (2002) Anti-inflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine, 9, 325–337;
159.
Rojas-DuranR, González-AspajoG, Ruiz-MartelC, BourdyG, Doroteo-OrtegaVH, Alban-CastilloJ, RobertG, AubergerP, DeharoE. (2011) Anti-inflammatory activity of Mitraphylline isolated from Uncaria tomentosa bark. Journal of Ethnopharmacology, 143, 801–804.
160.
Sandoval-ChacónM, ThompsonJH, ZhangX-J, LiuX, MannickEE, Sadowska-KrowickaH, CharbonnetRM, ClarkDA, MillerMJS. (1998) Anti-inflammatory actions of cat's claw: The role of NF-κB. Alimentary Pharmacology and Therapeutics, 12, 1279–1289;
161.
Allen-HallL, ArnasonJT, CanoP, LafrenieRM. (2010) Uncaria tomentosa acts as a potent TNF-α inhibitor through NF-κB. Journal of Ethnopharmacology, 127, 685–693;
162.
PilarskiR, Gurrola-DíazCM, García-LópezPM, SoldevilaG, OlejnikA, GrajekW, GulewiczK. (2013) Enhanced proapoptotic response of the promyelocytic leukemia HL-60 cells treated with an Uncaria tomentosa alkaloid preparation. Journal of Herbal Medicine, 3, 149–156;
163.
DietrichF, KaiserS, RockenbachL, FigueiróF, BergaminLS, CunhaFMD, MorroneFB, OrtegaGG, BattastiniAMO. (2014) Quinovic acid glycosides purified fraction from Uncaria tomentosa induces cell death by apoptosis in the T24 human bladder cancer cell line. Food and Chemical Toxicology, 67, 222–229.
164.
ZhangL, ZhangJ, ZhaoB, Zhao-WilsonX. (2012) Quinic acid could be a potential rejuvenating natural compound by improving survival of Caenorhabditis elegans under deleterious conditions. Rejuvenation Research, 15, 573–583.
165.
UchidaM, MiyajimaH, KochiyaM, SawaiY, YamadaM, SumaS, KohnoT. (2000) Effects of Uncaria guianensis on the oxidation of human low density lipoprotein and on the atherogenesis in Watanabe heritable hyperlipidemic rabbit. Japanese Pharmacology and Therapeutics, 28, 607–613.
166.
MurE, HartigF, EiblG, SchirmerM. (2002) Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for the treatment of rheumatoid arthritis. Journal of Rheumatololgy, 29, 678–681;
RosenbaumCC, O'MathunaDP, ChavezM, ShieldsK. (2010) Antioxidants and anti-inflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. AlternativesTherapies in Health and Medicine, 16, 32–40;
169.
SettyAR, SigalLH. (2005) Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Seminars in Arthritis and Rheumatism, 34, 773–784;
170.
PonceC, LozadaI, AkamineI. (2008) Efecto de Uncaria tomentosa (Willd) DC, (Uña de Gato) sobre la población y activación de células dendríticas en sangre periférica de pacientes con artritis reumatoide. Acta Médica Peruana, 25, 135–139.
171.
ShengY, LiL, HolmgrenK, PeroRW. (2001) DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study. Phytomedicine, 8, 275–282.
172.
VasishtK, VishavjitK. (2002) Trade and Production of herbal Medicines and Natural Products. United Nations Industrial Development Organization (UNIDO) p. 54
173.
International Trade Centre (ITC). (Dec.2009) Medicinal Plants and Extracts. Market News Service (Mns). q. ed. Bull. p 52;
174.
International Trade Centre (ITC). (Mar. 2011) Medicinal Plants and Extracts Market News Service (Mns). q. ed. Bull. p. 12, 69.
175.
World Trade Organization. Article (WTO) (2005) 27.3(B), Relationship between The Trips Agreement And The Cbd And Protection Of Traditional Knowledge And Folklore; Communication from Peru IP/C/W/441/ Rev.1.
176.
Gobierno de la República del Perú. (1993) Nuevo Texto Único De Productos De Exportación Prohibida; D. S. No. 070-93-EF, Ley No. 26496 y su Reglamento DS 007-96-AG, DS 008-96-AG, DS 013-96-AG, DS 001-97-AG y RM No. 373-97-AG.
177.
MatosR, RavinesR. (1981) El período Arcaico (5000 – 1800 a.C.) en Historia del Perú, Ed. MejiaBaca, TomoI pp. 157–250. Lima.
BrakoL. & ZarucchiL. (1993) Catalogue of the flowering plants and Gymnosperms of Peru. Monographs in Systematic Botany from the Missuri Botanical Garden. 45: i-xl – 1286 pp.
180.
DostertN, RoqueJ, CanoA, La TorreM, WeigendM. (2009) Hojas botánicas: Lepidium meyenii Walp. Proyecto Perúbiodiverso-PBD: Deutsche Gessellschaft fur Technische Zusammenarbeit (GTZ) GmbH: Programa Desarrollo Rural Sostenible-PDRS.
181.
BrinckmanJ, SmithE. (2004) Maca culture of the Junin Plateau. The Journal of Alternative and Complementary Medicine, 10. 426–430.
182.
GonzalesGF. (2006) Maca, de la tradición a la ciencia. CONCYTEC; Universidad Peruana Cayetano Heredia, Lima, Perú. 93pp.
183.
JohnsT. (1981) The añu and the maca. Journal of Ethnobiology, 7, 208–212;
184.
LiG, AmmermannU, QuirósCF. (2001) Glucosinolate contents in maca (Lepidium peruvianus Chacon) seeds, sprouts, mature plants and several derived commercial products. Economic Botany, 55, 255–262;
185.
PiacenteS, CarboneV, PlazaA, ZampelliA, PizzaC. (2002) Investigation of the tubers constituents of maca. Journal of Agricultural and Food Chemistry, 50, 5621–5625.
186.
ZhengBL, HeK, KimCH, RogersL, ShaoY, HuangZY, LuY, YanSJ, QienLC, ZhengQY. (2000) Effect of a lipidic extract from Lepidium meyenii on sexual behavior in mice and rats. Urology, 55, 598–602;
McCollomMM, VillinskiJR, McPhailKL, CrakerLE, GafnerS. (2005) Analysis of macamides in samples of Maca (Lepidium meyenii) by HPLC-UV-MS/MS. Phytochemical Analysis, 16, 463–469;
189.
ZhaoJ, MuhammadI, DunbarDC, MustafaJ, KhanIA. (2005) New alkamides from maca (Lepidium meyenii). Journal of Agricultural and Food Chemistry, 53, 690–693;
190.
ClementC, DiazD, ManriqueI, AvulaB, KhanIA, PonceDD, KunzC, MayerAC, KreuzerM. (2010) Secondary metabolites in maca as affected by hypocotyl color, cultivation history, and site. Agronomy Journal, 102, 431–439.
191.
DiniA, MigliuoloG, RastrelliL, SaturninoP, SchettinoO. (1994) Chemical composition of Lepidium meyenii. Food Chemistry, 49, 347–349;
192.
CamposD, ChirinosR, BarretoO, NorattoG, PedreschiR. (2013) Optimized methodology for the simultaneous extraction of glucosinolates, phenolic compounds and antioxidant capacity from maca (Lepidium meyenii). Industrial Crops and Products, 49, 747–754.
193.
CuiB, ZhengB, HeK, ZhengQY. (2003) Imidazole alkaloids from Lepidium meyenii. Journal of Natural Products, 66, 1101–1103.
194.
ZhaS, ZhaiQ, ChenJ, WangL, ZhanG, ZhanH, ZhaoB. (2014) Extraction, purification and antioxidant activities of the polysaccharides from maca (Lepidium meyenii). Carbohydrate Polymers, 111, 584–587.
195.
TellezMR, KhanIA, KobaisyM, SchraderKK, DayanFE, OsbrinkW. (2002) Composition of the essential oil of Lepidium meyenii. Phytochemistry, 61, 149–155.
ValentováK, BuckiováD, KřenV, PčknicováJ, UlrichováJ, ŠimánekV. (2006) The in vitro biological activity of Lepidium meyenii extracts. Cell Biology and Toxicology, 22, 91–99.
198.
del Valle MendozaJ, PumarolaT, GonzalesLA, del ValleLJ. (2014) Antiviral activity of maca (Lepidium meyenii) against human influenza virus. Asian Pacific Journal of Tropical Medicine, 7, S415–S420.
199.
VečeřaR, OrolinJ, ŠkottováN, KazdováL, OliyarnikO, UlrichováJ, ŠimánekV. (2007) The influence of maca (Lepidium meyenii) on antioxidant status, lipid and glucose metabolism in rat. Plant Foods for Human Nutrition, 62, 59–63.
200.
Pino-FigueroaA, NguyenD, MaherTJ. (2010) Neuroprotective effects of Lepidium meyenii (Maca). Annals of the New York Academy of Sciences, 1199, 77–85;
201.
AlmukadiH, WuH, BöhlkeM, KelleyCJ, MaherTJ, Pino-FigueroaA. (2013) The macamide N-3-methoxybenzyl-linoleamide is a time-dependent fatty acid amide hydrolase (FAAH) inhibitor. Molecular Neurobiology, 48, 333–339.
202.
Gonzales-CastañedaC, GonzalesGF. (2008) Hypocotyls of Lepidium meyenii (maca), a plant of the Peruvian highlands, prevent ultraviolet A-, B-, and C-induced skin damage in rats. Photodermatology Photoimmunology and Photomedicine, 24, 24–31;
203.
Gonzales-CastañedaC, RiveraV, ChirinosAL, EvelsonP, GonzalesGF. (2011) Photoprotection against the UVB-induced oxidative stress and epidermal damage in mice using leaves of three different varieties of Lepidium meyenii (maca). International Journal of Dermatology, 50, 928–938.
204.
AlvarezE, Alzamora-GonzalesL (2013) Effect of Lepidium meyenii (maca) on the production of three hematopoietic cytokines in splenocytes from immunosuppressed mice. Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, 12, 313–321.
205.
RubioJ, YucraS, GascoM, GonzalesGF. (2011) Dose response effect of black maca (Lepidium meyenii) in mice with memory impairment induced by ethanol. Toxicology Mechanisms and Methods, 21, 628–634;
206.
LiuX, RubioJ, QiongW, JiangZ, DangH, ChenS-L, GonzalesGF. (2011) Aqueous extract of black maca (Lepidium meyenii) on memory impairment induced by ovariectomy in mice. Evidence-based Complementary and Alternative Medicine, 2011, art. no. 253958;
207.
RubioJ, DangH, GongM, LiuX, ChenS-l, GonzalesGF. (2007). Aqueous and hydroalcoholic extracts of black maca (Lepidium meyenii) improve scopolamine-induced memory impairment in mice. Food and Chemical Toxicology, 45, 1882–1890;
208.
RubioJ, CaldasM, DávilaS, GascoM, GonzalesGF. (2006) Effect of three different cultivars of Lepidium meyenii (Maca) on learning and depression in ovariectomized mice. BMC Complementary and Alternative Medicine, 6, art. no. 23;
209.
AiZ, ChengA-F, YuY-T, YuL-J, JinW. (2014) Antidepressant-like behavioral, anatomical, and biochemical effects of petroleum ether extract from maca (Lepidium meyenii) in mice exposed to chronic unpredictable mild stress. Journal of Medicinal Food, 17, 535–542;
210.
IkeuchiM, KoyamaT, TakeiS, KinoT, YazawaK. (2009) Effects of benzylglucosinolate on endurance capacity in mice. Journal of Health Science, 55, 178–182.
211.
GascoM, VillegasL, YucraS, RubioJ, GonzalesGF. (2007) Dose-response effect of red maca (Lepidium meyenii) on benign prostatic hyperplasia induced by testosterone enanthate. Phytomedicine, 14, 460–464;
212.
GonzalesGF, MirandaS, NietoJ, FernándezG, YucraS, RubioJ, YiP, GascoM. (2005) Red maca (Lepidium meyenii) reduced prostate size in rats. Reproductive Biology and Endocrinology, 3, art. no. 5.
213.
ZhangY, YuL, AoM, JinW. (2006) Effect of ethanol extract of Lepidium meyenii Walp. on osteoporosis in ovariectomized rat. Journal of Ethnopharmacology, 105, 274–279;
214.
GonzalesC, Cárdenas-ValenciaI, Leiva-RevillaJ, Anza-RamirezC, RubioJ, GonzalesGF. (2010) Effects of different varieties of Maca (Lepidium meyenii) on bone structure in ovariectomized rats. Forschende Komplementarmedizin, 17, 137–143.
215.
Ruiz-LunaAC, SalazarS, AspajoNJ, RubioJ, GascoM, GonzalesGF. (2005) Lepidium meyenii (Maca) increases litter size in normal adult female mice. Reproductive Biology and Endocrinology, 3, art. no. 16, 6 p;
216.
GonzalesGF, RubioJ, ChungA, GascoM, VillegasL. (2003) Effect of alcoholic extract of Lepidium meyenii (Maca) on testicular function in male rats. Asian Journal of Andrology, 5, 349–352;
217.
GonzalesC, RubioJ, GascoM, NietoJ, YucraS, GonzalesGF. (2006) Effect of short-term and long-term treatments with three ecotypes of Lepidium meyenii (MACA) on spermatogenesis in rats. Journal of Ethnopharmacology, 103, 448–454;
218.
ChungF, RubioJ, GonzalesC, GascoM, GonzalesGF. (2005) Dose-response effects of Lepidium meyenii (Maca) aqueous extract on testicular function and weight of different organs in adult rats. Journal of Ethnopharmacology, 98, 143–147;
219.
GascoM, AguilarJ, GonzalesGF. (2007) Effect of chronic treatment with three varieties of Lepidium meyenii (Maca) on reproductive parameters and DNA quantification in adult male rats. Andrologia, 39, 151–158;
220.
YucraS, GascoM, RubioJ, NietoJ, GonzalesGF. (2008) Effect of different fractions from hydroalcoholic extract of black maca (Lepidium meyenii) on testicular function in adult male rats. Fertility and Sterility, 89, 1461–1467;
221.
RubioJ, RiquerosMI, GascoM, YucraS, MirandaS, GonzalesGF. (2006) Lepidium meyenii (Maca) reversed the lead acetate induced-damage on reproductive function in male rats. Food and Chemical Toxicology, 44, 1114–1122;
222.
GonzalesGF, GascoM, CórdovaA, ChungA, RubioJ, VillegasL. (2004) Effect of Lepidium meyenii (Maca) on spermatogenesis in male rats acutely exposed to high altitude (4340 m). Journal of Endocrinology, 180, 87–95;
223.
Bustos-ObregónE, YucraS, GonzalesG.F. (2005) Lepidium meyenii (Maca) reduces spermatogenic damage induced by a single dose of malathion in mice. Asian Journal of Andrology, 7, 71–76.
224.
UchiyamaF, JikyoT, TakedaR, OgataM. (2014) Lepidium meyenii (Maca) enhances the serum levels of luteinising hormone in female rats. Journal of Ethnopharmacology, 151, 897–902;
225.
GascoM, YucraS, RubioJ, GonzalesGF. (2008) Lepidium meyenii (Maca) varieties did not alter female reproductive parameters in adult intact rats. Journal of Complementary and Integrative Medicine, 5, art. no. 15;
226.
ZhangY, YuL, JinW, AoM. (2014) Effect of ethanolic extract of Lepidium meyenii Walp on serum hormone levels in ovariectomized rats. Indian Journal of Pharmacology, 46, 416–419;
227.
ZhangY-Z, YuL-J, AoM-Z. (2008) Effect of ethanol extract of Lepidium meyenii on serum hormone and blood lipid levels in ovariectomized rats. Chinese Journal of New Drugs, 17, 2112–2114;
228.
OshimaM, GuY, TsukadaS. (2003) Effects of Lepidium meyenii Walp and Jatropha macrantha on Blood levels of estradiol-17β, progesterone, testosterone and the rate of embryo implantation in mice. Journal of Veterinary Medical Science, 65, 1145–1146.
229.
LavanaA, VázquezR, Palma-IrizarryM, OrihuelaA. (2013) Effect of maca (Lepidium meyenii) supplementation on some libido and semen characteristics in hair sheep rams (Ovis aries). Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, 12, 238–242;
230.
CiceroAFG, BandieriE, ArlettiR. (2001) Lepidium meyenii Walp. improves sexual behaviour in male rats independently from its action on spontaneous locomotor activity. Journal of Ethnopharmacology, 75, 225–229;
231.
ClémentC, KneubühlerJ, UrwylerA, WitschiU, KreuzerM. (2010) Effect of maca supplementation on bovine sperm quantity and quality followed over two spermatogenic cycles. Theriogenology, 74, 173–183;
232.
LentzA, GravittK, CarsonCC, MarsonL, GiulianoF. (2007) Acute and chronic dosing of Lepidium meyenii (Maca) on male rat sexual behavior. Journal of Sexual Medicine, 4, 332–340.
233.
BrooksNA, WilcoxG, WalkerKZ, AshtonJF, CoxMB, StojanovskaL (2008) Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. Menopause, 15, 1157–1162;
234.
DordingCM, FisherL, PapakostasG, FarabaughA, SonawallaS, FavaM, MischoulonD. (2008) A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience and Therapeutics, 14, 182–191;
235.
MeissnerHO, Reich-BilinskaH, MrozikiewiczPM, MsciszA, LowickaA. (2005) Hormone-balancing and pharmacological effects of therapeutic doses of Lepidium peruvianum Chacon (Maca-GO) in post-menopausal women. 16th Annual Meeting of the North American Menopause Society;
236.
MeissnerHO, MsciszA, Reich-BilinskaH, KapczynskiW, MrozikiewiczP, Bobkiewicz-KozlowskaT, KedziaB, LowickaA, BarchiaI. (2006) Hormone-balancing effect of pregelatinized organic maca (Lepidium peruvianum Chacon): (II) Physiological and symptomatic responses of early-postmenopausal women to standardized doses of maca in double blind, randomized, placebocontrolled, multi-centre clinical study. International Journal of Biomedical Sciences, 2, 360–374;
237.
MeissnerHO, KapczynskiW, MsciszA, LutomskiJ. (2005) Use of gelatinized maca (Lepidium peruvianum Chacon) in early-postmenopausal women – a pilot study. International Journal of Biomedical Sciences, 1, 33–45;
238.
MeissnerHO, Reich-BilinskaH, KedziaB, MsciszA. (2006) Therapeutic effect of pre-gelatinized Maca (Lepidium peruvianum Chacon) used as non-hormonal alternative to HRT in peri-menopausal women. International Journal of Biomedical Sciences, 2, 143–159.
239.
ReaJ. (1994) Andean roots. In: Hernandez BermejoJ.E., LeonJ. (Eds.), Neglected Crops: 1492 from a Different Perspective. FAO, Rome, Italy, pp. 165.
240.
HermannM, BernetT. (2009) The transition of maca from neglect to market prominence: Lessons for improving use strategies and market chains of minor crops. Agricultural Biodiversity and Livelihoods. Bioversity International, Rome, Italy.
Programa Iberoamericano de Ciencia y Tecnologia Para el Desarrollo – CYTED Red Temática 112RT0460 “CORNUCOPIA. (2014) ‘'Physalis peruviana L.: Fruta Andina para el Mundo. 230pp.
245.
DostertN, RoqueJ, CanoA., La TorreM, WeigendM. (2012) Hojas botánicas: Aguaymanto Physalis peruviana L. Proyecto Perúbiodiverso. PBD: Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ) GmbH: Programa Desarrollo Rural Sostenible-PDRS.
246.
LagosT, VallejoF, CriolloH., MuñozJ. (2008) Biología reproductiva de la uchuva. Acta Agronomica (Palmira), 57, 81–87.
247.
SalazarMR, JonesJW, ChavesB, CoomanA. (2008) A model for the potential production and dry matter distribution of Cape gooseberry (Physalis peruviana L.). Acta Horticulturae, 115, 142–148.
248.
VicuñaZ. (2011) Inventario de Plantas Medicinales del Tawantinsuyo.Cesys, Lima, Perú. Tomo 1. 403pp.
249.
BerdoncesJL. (2010) Gran Enciclopedia de las Plantas Medicinales. Tikal Eds. Barcelona., 1096 pp.
RamadanM, MoerselJ. (2003) Oil goldenberry (Physalis peruviana L.). Journal of Agricultural and Food Chemistry, 51, 969–974.
252.
MayorgaH, DuqueC, KnappH, WinterhalterP. (2002) Hydroxyester disaccharides from fruits of cape gooseberry Physalis peruviana. Phytochemistry, 59, 439–445;
253.
LatzaS, GanberD, BergerRG. (1996) Carbohydrate esters of cinnamic acid from fruits of Physalis peruviana, Psidium guajava and Vaccinium vitis-idaea.Phytochemistry, 43, 481–485.
254.
GlotterE. (1991) Withanolides and related ergostane-type steroids. Natural Products Reports, 8, 415–440.
255.
YilmaztekinM. (2014) Characterization of potent aroma compounds of cape gooseberry (Physalis Peruviana L.) fruits grown in Antalya through the determination of odor activity values. International Journal of Food Properties, 17, 469–480;
256.
YilmaztekinM. (2014) Analysis of volatile components of cape gooseberry (Physalis peruviana L.) grown in turkey by HS-SPME and GC-MS. The Scientific World Journal, 2014, art. no. 796097.
257.
FangST, LiuJK, LiB. (2012) Ten new withanolides from Physalis peruviana. Steroids, 77, 36–44;
258.
FangST, LiB, LiuJK. (2009) Two new withanolides from Physalis peruviana. Helvetica Chimica Acta, 92, 1304–1308;
259.
FangST, LiuJK, LiB. (2010) A novel 1,10-seco withanolide from Physalis peruviana. Journal of Asian Natural Products Research, 12, 618–622;
260.
LanYH, ChangFR, PanMJ, WuCC, WuSJ, ChenSL, WangSS, WuMJ, WuYC. (2009) New cytotoxic withanolides from Physalis peruviana. Food Chemistry, 116, 462–469.
261.
BagchiA, NeogiP, SahaiM, RayAB, OshimaY, HikinoH. (1984) Withaperuvin E and nicandrin B, withanolides from Physalis peruviana and Nicandra physaloides.Phytochemistry, 23, 853–855;
262.
NeogiP, SahaiM, RayA. (1986) Withaperuvins F and G, two withanolides of Physalis peruviana roots. Phytochemistry, 26, 243–247;
263.
OshimaY, HikinoH, SahaiM, RayAB. (1989) Withaperuvin H, a withanolide of Physalis peruviana roots. Journal of the Chemical Society, Chemical Communications, 10, 628–629;
264.
SakuraiK, IshiiH, KobayashiS, IwaoT. (1976) Isolation of 4β-hydroxywithanolide E from Physalis peruviana L. Chemical and Pharmaceutical Bulletin, 24, 1403–1405;
265.
AliA, SahaiM, RayAB, SlatkinDJ. (1984) Physolactone C, a new withanolide from Physalis peruviana. Journal of Natural Products, 47, 648–651;
RopO, MlcekJ, JurikovaT, ValsikovaM. (2012) Bioactive content and antioxidant capacity of Cape gooseberry fruit. Central European Journal of Biology, 7, 672–679;
270.
TripahtiYB, ShuklaS. (1995) Withaperuvin-E a new free radical scavenger isolated from Physalis peruviana Y.B. Tripathi & Savita Shukla IndianJournal of Biology & Biophysics, 32, 308–309;
271.
LicodiedidoffS, KoslowskiLAD, RibaniRH. (2013) Flavonols and antioxidant activity of Physalis peruviana L. fruit at two maturity stages. Acta Scientiarum -Technology, 35, 393–399;
272.
WuSJ, TsaiJY, ChangSP, LinDL, WangSS, HuangSN, NgLT. (2006) Supercritical carbon dioxide extract exhibits enhanced antioxidant and anti-inflammatory activities of Physalis peruviana. Journal of Ethnopharmacology, 108, 407–413.
273.
FrancoLA, MatizGE, CalleJ, PinzónR, OspinaLF. (2007) Anti inflammatory activity of extracts and fractions obtained from Physalis peru-viana L. calyces. Biomedica, 27, 110–115;
274.
ToroRM, AragónDM, OspinaLF, RamosFA, CastellanosL. (2014) Phytochemical analysis, antioxidant and anti-inflammatory activity of calyces from Physalis peruviana. Natural Product Communications, 9, 1573–1575.
275.
PardoJM, FontanillaMR, OspinaLF, EspinosaL. (2008) Determining the pharmacological activity of Physalis peruviana fruit juice on rabbit eyes and fibroblast primary cultures. Investigative Ophthalmology and Visual Science, 49, 3074–3079.
276.
ZakiAY, El-AlfyTSM, El GoharyHMA. (1987) Study of withanolides, physalins, antitumor and antimicrobial activity of Physalis peruviana. Egypitian Journal of Pharmaceutical Sciences, 28, 235–245;
277.
Franco-OspinaLA, Matiz-MeloGE, Pájaro-BolívarI.B, Gómez-EstradaHA. (2013) In vitro antibacterial activity of extracts and fractions of Physalis peruviana L. and Caesalpinia pulcherrima (L.) Swartz. Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, 12, 230–237.
278.
ElligerCA, HaddonWF, HardenL, WaissAC, WongRY. (1994) Insect Inhibitory Steroidal Saccharide Esters from Physalis peruviana. Journal of Natural Products, 57, 348–356;
AscherKRS, NemnyNE, EliyahuM, KirsonI, AbrahamA, GlotterE. (1980) Insect antifeedant properties of withanolides and related steroids from Solanaceae. Experientia, 36, 998–999.
281.
ChangJC, LinCC, WuSJ, LinDL, WangSS, MiawCL, NgLT. (2008) Antioxidative and hepatoprotective effects of Physalis peruviana extract against acetaminophen-induced liver injury in rats. Pharmaceutical Biology, 46, 724–731;
282.
TajD, KhanH, SultanaV, AraJ, Ehteshamul-HaqueS. (2014) Anti hepatotoxic effect of golden berry (Physalis peruviana Linn.) in carbon tetrachloride (CCl4) intoxicated rats. Pakistan Journal of Pharmaceutical Sciences, 27, 491–494;
283.
ArunM, AshaVV. (2007) Preliminary studies on antihepatotoxic effect of Physalis peruviana Linn. (Solanaceae) against carbon tetrachloride induced acute liver injury in rats. Journal of Ethnopharmacology, 111, 110–114;
284.
Al-OlayanEM, El-KhadragyMF, ArefAM, OthmanMS, KassabRB, Abdel MoneimAE. (2014) The potential protective effect of Physalis peruviana L. against carbon tetrachloride-induced hepatotoxicity in rats is mediated by suppression of oxidative stress and downregulation of MMP-9 expression. Oxidative Medicine and Cellular Longevity, 2014, Article ID 381413, 12 pp;
285.
El-GengaihiSE, HamedMA, Khalaf-AllahAE-RM, MohammedMA. (2013) Golden berry juice attenuates the severity of hepatorenal injury. Journal of Dietary Supplements, 10, 357–369;
286.
El-GengaihiSE, HassanEE, HamedMA, ZahranHG, MohammedMA. (2013) Chemical composition and biological evaluation of Physalis peruviana root as hepato-renal protective agent. Journal of Dietary Supplements, 10, 39–53.
287.
PerkBO, IlginS, AtliO, DuymusHG, SirmagulB. (2013) Acute and subchronic toxic effects of the fruits of Physalis peruviana L. Evidence-based Complementary and Alternative Medicine, 2013, art. no. 707285.
288.
MoraAC, AragónDM, OspinaLF. (2010) Effects of Physalis peruviana fruit extract on stress oxidative parameters in streptozotocin-diabetic rats. Latin American Journal of Pharmacy, 29, 1132–1136;
289.
KasaliFM, KadimaJN, MpianaPT, NgboluaK-T-N, TshibanguDST. (2013) Assessment of antidiabetic activity and acute toxicity of leaf extracts from Physalis peruviana L. in guinea-pig. Asian Pacific Journal of Tropical Biomedicine, 3, 841–846;
290.
RamadanMF, HassanNA, ElsanhotyRM, SitohyMZ. (2013) Goldenberry (Physalis peruviana) juice rich in health-beneficial compounds suppresses high-cholesterol diet-induced hypercholesterolemia in rats. Journal of Food Biochemistry, 37, 708–722.
291.
Quispe-MauricioA, CallacondoD, RojasJ, ZavalaD, PossoM, VaisbergA. (2009) Actividad citotóxica de Physalis peruviana (Aguaymanto) en cultivos celulares de adenocarcinoma colorectal, próstata y leucemia mieloide crónica. Revista de Gastroenterología del Perú, 29, 239–246;
292.
WuS-J, NgL-T, LinD-L, HuangS-N, WangS-S, LinC-C. (2004) Physalis peruviana extract induces apoptosis in human Hep G2 cells through CD95/CD95L system and the mitochondrial signaling transduction pathway. Cancer Letters, 215, 199–208;
293.
WuS-J, NgL-T, ChenC-H, LinD-L, WangS-S, LinC-C. (2004) Antihepatoma activity of Physalis angulata and P. peruviana extracts and their effects on apoptosis in human Hep G2 cells. Life Sciences, 74, 2061–2073;
294.
YenC-Y, ChiuC-C, ChangF-R, ChenJY, HwangC-C, HseuY-C, YangH-L, LeeAY-L, TsaiM-T, GuoZ-L, ChengY-S, LiuY-C, LanY-H, ChangY-C, KoY-C, ChangH-W, WuY-C. (2010) 4β-Hydroxywithanolide E from Physalis peruviana (golden berry) inhibits growth of human lung cancer cells through DNA damage, apoptosis and G2/M arrest. BMC Cancer, 10, art. no. 46;
295.
ChiuC-C, HaungJ-W, ChangF-R, HuangK-J, HuangH-M, HuangH-W, ChouC-K, WuY-C, ChangH-W. (2013) Golden berry-derived 4β-hydroxy-withanolide E for selectively killing oral cancer cells by generating ROS, DNA damage, and apoptotic pathways. PLoS ONE, 8, art. no. e64739.
296.
RodríguezS, RodríguezE. (2007) Efecto de la ingesta de Physalis peruviana (aguaymanto) sobre la glicemia postprandial en adultos jóvenes. Revista Medica Vallejiana, 4, 43–53.
297.
International Trade Centre ITC. (2013) Market Analysis for Three Peruvian Natural Ingredients. Golden berry.
RojasLB, UsubillagaAN. (1995) Essential oil of Minthostachys mollis Grisebach from Venezuela. Journal of Essential Oil Research, 7, 211–213;
304.
SenatoreF, UrrunagaE, UrrunagaR, Della PortaG, De FeoV. (1998) Flavour & Fragance Journal, 13, 1–4;
305.
FuertesCM, ChipanaYM. (2001) Estudio comparativo del aceite esencial de Minthostachys mollis (Kunth) Griseb “muña” de tres regiones peruanas por cromatografía de gases y espectrometría de masas. Ciencia e Investigación, IV, 23–39;
306.
MalagónO, VilaR, IglesiasJ, ZaragozaT, CañigueralS. (2003) Composition of the essential oil of four medicinal plants from Ecuador. Flavor & Fragance, 18, 527–531;
307.
Alonso-AmelotME, UsbillagaA, Avila-NuñezJL, Oliveros-BastidasA, AvendañoM. (2006) Effect of Minthostachys mollis essential oil and volatiles on seedlings lettuce, tomato, cucumber and Bidens pilosa.Allelopathy Journal, 18, 267–275;
308.
Schmidt- LebuhnAN. (2008) Ethnobotany, biochemistry and pharmacology of Minthostachys (Lamiaceae). Journal of Ethnopharmacology, 118, 343–353;
309.
CanoC, BonillaP, RoqueM, RuizJ. (2008) Actividad antimicótica in vitro y metabolitos del aceite esencial de las hojas de Minthostachys mollis (muña). Revista Peruana Medicina Experimental Salud Publica, 2513, 298–301;
310.
MoraFD, AraqueM, RojasLB, RamírezR, SilvaB, UsubillagaA. (2009) Chemical composition and in vitro antibacterial activity of the essential oil of Minthostachys mollis Kunth) Griseb Vaught from the Venezuela Andes. Natural Product Communications, 4, 997–1000;
311.
Olivera-VerbelJ, Gonzáles-CerveraT, Guette-FernándezJ, Jaramillo-ColoradoB, StachenkoE. (2010) Chemical composition and antioxidant activity of essential oil isolated from Colombian plants. Brazilian Journal of Pharmacognosy, 20, 568–574;
312.
van BarenCM, Di Leo LiraP, ElechosaMA, MolinaAM, JuarezMA, MartinezA, PerelmanS, BandoniAL. (2014) New insights into the chemical biodiversity of Minthostachys mollis in Argentina. Biochemical Systematics and Ecology, 57, 374–383.
313.
WollenweberE, DoerrM, WatonH, Favre-BanvinI. (1993) Flavonoid aglycones and dihydrostilbene from the frond exudate of Notholaena nivea. Phytochemistry, 33, 611–612;
314.
De CioffiG, MontoroP, Lock de UgazO, VassalloA, SeverinoL, PizzaC, De TommasiN. (2011) Antioxidant bibenzyl derivatives from Notholaena nívea Desv. Molecules, 16, 227–2541.
ChávezH, Estévez-BraunA, RaveloAG, GonzálezAG. (1998) Friedalene triterpenoids from Maytenus macrocarpa. Journal of Natural Products, 61, 82–85;
317.
ChávezH, RodríguezG, Estévez-BraunA, RaveloAG, Estévez-ReyesR, GonzálezAG, Fdez-PuenteJ, García-GrávalosD. (2000) Macrocarpins A-D, new cytotoxic nor triterpenes from Maytenus macrocarpa. Bioorganic & Medicinal Chemistry Letters, 10, 759–762;
318.
ChávezH, CalloN, Estévez-BraunA, RaveloAG, GonzálezAG. (1999) Sesquiterpene polyol esters from the leaves of Maytenus macrocarpa. Journal of Natural Products, 62, 1576–1577;
319.
TorpocoV, ChávezH, Estévez-BraunA, RaveloAG. (2007) New dammarene triterpene from Maytenus macrocarpa. Chemical & Pharmaceutical Bulletin, 15, 812–814;
320.
ChávezH, Estévez-BraunA, RaveloAG, GonzálezAG. (1997) First examples of dammarane triterpenes isolated from Celastraceae. Tetrahedron, 53, 6465–6472;
321.
ChávezH, ValdiviaE, Estévez-BraunA, RaveloAG. (1998) Structure of new bioactive triterpene related to 22-β-hydroxy-tingenone. Tetrahedron, 54, 13579–13590;
HuacchoJJ, CaverES, QuezadaMA, LaraAM, LluenSE, ParagullaAA, RojasFJ, LojaB, AlvaradoA, MujocaJ, SalazarA. (2012) Efectos sobre la temperatura, frecuencia respiratoria, frecuencia cardiaca y electrocardiograma de Maytenus macrocarpa (Ruiz & Pavon) Briq. Revista Cubana de Plantas Medicinales, 17, 233–243;
324.
Robles-PizarroV, Tarqui-CabreraL, Rodriguez-CollazosN, Morales-ChauA, De La Cruz-ManyariJ, Ríos-MelgarK, Rivera-CruzadoD, Rubio-GonzálesA, Santa Cruz-ContrerasC, Velazco-CurayG, Loja-HerreraB, Alvarado-YarascaA, Castañeda-CastañedaB, Salazar-GranaraA. (2014) Efecto antinociceptivo del extracto etanólico de las hojas de Maytenus macrocarpa (Ruiz & Pavon.) Briq. “chuchuhuasi” mediante la prueba de contorsiones abdominales en ratones. Horizonte Médico, 14, 6–10;
325.
Meléndez-EspírituS, Huaccho-RojasJ, SantosCajahuanca F, Abanto-CabezaC, Jáuregui-FarfánJ, Mendoza-ToribioJ, Morales-ZentenoE, Salgado-SilvaL, Sueyoshi-HernándezH, Robles-OjedaM, Loja-HerreraB, Alvarado-YarascaA, Salazar-GranaraA. (2013) Interacciones farmacológicas de las hojas de Maytenus macrocarpa o “chuchuhuasi” con fármacos inhibitorios y estimuladores de la motilidad intestinal. Acta Médica Peruana, 30, 114–119.
NapolitanoA, BenavidesA, PizzaC, PiacenteS. (2011) Quantitative online profiling of ceramides and cerebrosides by high performance liquid chromatography coupled with electrospray ionization ion trap tandem mass spectrometry: The case of Dracontium loretense. Journal of Pharmaceutical and Biomedical Analysis, 55, 23–30.
328.
Chung-YingLi, Hee-WoongKim, Se-RaWon, Hwang-KeeMin, Ki-JinPark, Jong-YeolPark, Mun-SeobAhn, Hae-IkRhee (2008) Corn husk as potential source of anthocyanins. Journal of Agricultural and Food Chemistry, 56, 11413–11416;
329.
Pascual-TeresaS, Santos-BuelgaC, Rivas-GonzaloJC. (2002) LC-MS analysis of anthocyanins from purple corn cob. Journal of Science Food Agricultural, 82, 1003–1006;
330.
AokiH, KuzeN, KatoY. (2002) Anthocyanins isolated from purple corn (Zea mays L.). Foods and Food Ingredients Journal, 199, 41–45;
331.
YangZ, ZhaiW. (2010) Identification and antioxidant activity of anthocyanins extracted from the seed and cob of purple corn. Innovative Food Science Emerging Technologies, 11, 169–176;
Ramirez-EscuderoF, MuñozAM, Alvarado-OrtízCC, AlvaradoA, YañezJA. (2012) Purple corn (Zea mays L.) Phenolic compound profile and its assessment as an agent against oxidative stress in isolated mouse organs. Journal of Medicinal Food, 15, 206–215.
334.
HamakerB, VallesC, GilmanR, HardmeierR, ClarkD, GarciaH. (1992) Amino acid and fatty acid profiles of the Inca peanut (Plukenetia volubilis). Cereal Chemistry, 69, 461–463;
335.
GuillénMD, RuizA, CaboN, ChirinosR, PascualG. (2003) Characterization of sacha inchi (Plukenetia volubilis L.) oil by FTIR spectroscopy and 1H NMR. Comparison with linseed oil. Journal of the American Oil Chemists'Society, 80, 755–762;
336.
BondioliP, BellaD, RetikeP. (2006) Alpha linolenic acid rich oils. Composition of Plukenetia volubilis (Sacha Inchi) oil from Peru. La Rivista Italiana Delle Sostanze Grasse, LXXIII, 120–123;
337.
Follegati-RomeroLA, PiantinoCR, GrimaldiR, CabralFA. (2009) Supercritical CO2 extraction of omega-3 rich oil from Sacha inchi (Plukenetia volubilis L.) seeds, Journal of Supercritical Fluids, 49, 323–329;
338.
GutiérrezLF, RosadaLM, JiménezÁ. (2011) Chemical composition of Sacha Inchi (Plukenetia volubilis L.) seeds and characteristics of their lipid fraction. Grasas y Aceites, 62, 76–78;
339.
FanaliC, DugoL, CacciolaF, BeccariaM, GrassoS, DachàM, DugoP, MondelloL. (2011) Chemical characterization of sacha inchi (Plukenetia volubilis L.) oil. Journal of Agricultural and Food Chemistry, 59, 13043–13049;
340.
MaurerNE, Hatta-SakodaB, Pascual-ChagmanG, Rodriguez-SaonaLE. (2012) Characterization and authentication of a novel vegetable source of omega-3 fatty acids, sacha inchi (Plukenetia volubilis L.) oil.Food Chemistry, 134, 1173–1180;
341.
ChirinosR, ZuloetaG, PedreschiR, MignoletE, LarondelleY, CamposD. (2013) Sacha inchi (Plukenetia volubilis): a seed source of polyunsaturated fatty acids, tocopherols, phytosterols, phenolic compounds and antioxidant capacity. Food Chemistry, 141, 1732–1739;
342.
MuñozA, RamosF, AlvaradoC, CastañedaB, BarnettE, YáñezJ. (2010) Evaluación del contenido de fitoesteroles, compuestos fenólicos y métodos químicos para determinar la actividad antioxidante en semilla de sacha inchi (Plukenetia volubilis L.). Revista de la Sociedad Química del Perú, 76, 234–241.
343.
HuamánJ, ChávezK, CastañedaE, CarranzaS, ChávezT, BeltránY, CaffoC, CadilloR, CadenillasJ. (2008) Effect of Plukenetia volubilis Linneo (sacha inchi) on postprandial triglyceridemia. Anales de la Facultad de Medicina UNMSM, 69, 263–266;
344.
GonzalesGF, GonzalesC, VillegasL. (2014) Exposure of fatty acids after a single oral administration of sacha inchi (Plukenetia volubilis L.) and sunflower oil in human adult subjects. Toxicology Mechanisms and Methods, 24, 60–69;
345.
GonzalesGF, GonzalesC. (2014) A randomized, double-blind placebo-controlled study on acceptability, safety and efficacy of oral administration of sacha inchi oil (Plukenetia volubilis L.) in adult human subjects. Food and Chemical Toxicology, 65, 168–176.
346.
Lacaille-DuboisM, GalleK, WagnerH. (1996) Secoiridoids and xanthones from Gentianella nitida. Planta Medica, 62, 365–368;
347.
KawaharaN, MasudaK, SekitaS, SatakeM. (2001) A new secoiridoid glucoside amaronitidin from the Peruvian folk medicine “hercampuri” (Gentianella nitida).Chemical & Pharmaceutical Bulletin, 49, 771–772;
348.
CalloN, LockO, AlvarezC, JurupeH. (2001) Xantonas y actividad hipoglicemiante de G. nítida y G. tristicha.Boletín de la Sociedad Química, 67, 195–206;
349.
KawaharaN, NozawaM, FloresD, BonillaP, SekitaS, SatakeM, KawaiK. (1997) Nitidasin, a novel sesteterpenoid from the Peruvian folk medicine “hercampuri” Gentianella nitida. Chemical & Pharmaceutical Bulletin, 45, 1717–1719;
350.
KawaharaN, NozawaM, KurataA, HakamatsukaT, SekitaS, SatakeM. (1999) A novel sesteterpenoid, Nitiol, as a potent enhancer of IL-2 gene expression in a human T cell line from the Peruvian folk medicine “hercampuri” (Gentianella nitida).Chemical & Pharmaceutical Bulletin, 47, 1344–1345.
351.
RojasR, DoroteoV, BustamanteB, BauerJ, LockO. (2004) Antimicrobial and free radical scavenging activity of Gentianella nitida. Fitoterapia, 75, 754–757.
